Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:2.3.1.177 (
BIS
)
957
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Impulse control disorders
(ICDs) are frequent in Parkinson's disease (PD). Aim of the present study was to investigate cognition and behaviour in PD patients with and without ICDs, in order to identify potential early clinical features which might be associated to the development of ICDs. We recruited 17 PD patients with ICDs and 17 without ICDs, matched for several clinical variables, without clinically significant cognitive deficits. Assessments included behavioural scales and a neuropsychological battery, including the Iowa Gambling Task (IGT). In patients with ICDs, the total score of the
BIS
and the Motor Impulsivity subscore were significantly higher than in patients without ICDs. In patients with ICDs, we observed only statistical trends towards a worse performance on neuropsychological tasks (go-no-go subtest of the Frontal Assessment Battery, oral verb naming task, copying of drawings with landmarks) sensitive to frontal lobe dysfunction (FLD) and on the IGT (loss of a greater amount of money, more risky choices). As compared to patients without ICDs, they reported a more than threefold number of errors on the interference subtest of Stroop test, which is also sensitive to FLD. Although this study did not show any significant difference between PD patients presenting ICDs as compared with patients without ICDs on neuropsychological variables, some preliminary evidence was detected suggesting a trend toward a worse performance of the PD-
ICD
group on few neuropsychological tasks which are at least partially sensitive to frontal lobe dysfunction, including tasks sensitive to dysfunction of ventral fronto-striatal loops.
...
PMID:Neuropsychological features of patients with Parkinson's disease and impulse control disorders. 2351 19
Introduction:
Impulse control disorders
(ICDs) are a common complication of Parkinson's disease (PD) receiving dopamine agonist (DAA) Impulsivity is considered an underlying mechanism but evidence of this relationship is scarce. To explore the relationship between impulsivity and the presence and severity of
ICD
in PD.
Methods:
Prospective cross-sectional study of consecutive PD outpatients. Patients with dementia or previously known ICDs were excluded. Two measures of impulsivity were assessed: Barratt Impulsiveness Scale (
BIS
-11) for impulsiveness trait (main exposure) and commission errors in the Continuous Performance Test (CE) for motor inhibition. Main outcomes were diagnosis of
ICD
based on a comprehensive clinical interview and severity of
ICD
based on the Questionnaire for Impulsive-Compulsive Disorders.
Results:
Of 100 patients (mean [SD] age, 67.2 [8.8], 54 male), 31 had
ICD
. Patients with ICDs were 5.3 years younger (
p
= 0.01), used more frequently dopamine agonist (
p
= 0.02), alcohol (
p
= 0.009) and tobacco (
p
= 0.02). They were not more impulsive on
BIS
-11 (56 vs. 58,
p
= 0.23, adjusted
p
= 0.46) and CE (
p
= 0.96). No relationship was found between dopaminergic medications and impulsivity or
ICD
severity. Among patients with
ICD
, impulsivity was correlated with
ICD
severity (
BIS
-11
r
= 0.33,
p
= 0.001, adjusted
p
= 0.002, CE
r
= 0.53,
p
= 0.006). Multivariate regression analysis confirmed the independent predictive role of both measures.
Conclusions:
Impulsivity is not associated with increased prevalence of
ICD
in PD but it is strongly linked to
ICD
severity. When considering dopamine replacement therapy, assessment of impulsivity may be a useful approach to detect those patients at risk of severe forms of
ICD
.
...
PMID:Parkinson's Disease: Impulsivity Does Not Cause Impulse Control Disorders but Boosts Their Severity. 3032 75